Keyphrases
Acute Rejection
25%
Adjusted Hazard Ratio
75%
Alemtuzumab
50%
Basiliximab
50%
Calcineurin Inhibitor Withdrawal
100%
Confidence Interval
100%
First Year
25%
Free Flap Transplantation
50%
Graft Failure Risk
50%
HLA Matching
100%
Immunosuppression
25%
Kidney Transplant Recipients
50%
Kidney Transplantation
100%
Living Kidney Transplant
50%
Low-risk Population
25%
National Database
25%
Organ Procurement
75%
Organ Transplantation
75%
Registry Data
25%
Rejection Rate
25%
Single Center
50%
Thymoglobulin
50%
Very Low Risk
25%
Medicine and Dentistry
Acute Graft Rejection
16%
Alemtuzumab
33%
Basiliximab
33%
Calcineurin Inhibitor
100%
Graft Failure
33%
Haplotype
100%
Hazard Ratio
50%
Immunosuppressive Treatment
16%
Kidney Graft
50%
Kidney Transplantation
100%
Low Risk Population
16%
Organ Transplantation
100%
Thymocyte Antibody
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Graft Rejection
33%
Alemtuzumab
66%
Basiliximab
66%
Calcineurin Inhibitor
100%
Graft Failure
66%
Thymocyte Antibody
66%